Item 2.02 Results of Operations and Financial Condition. On October 21, 2020, Biogen Inc. (the "Company") issued a press release announcing its results of operations and financial condition for the third quarter ended September 30, 2020. A copy of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference. The press release is being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that Section, nor shall such document be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Item 8.01 Other Events.

On October 20, 2020, the Board of Directors of the Company authorized a program to repurchase up to $5.0 billion of the Company's common stock (the "2020 Share Repurchase Program"). The 2020 Share Repurchase Program does not have an expiration date. All share repurchases under the 2020 Share Repurchase Program will be retired.

Item 9.01 Financial Statements and Exhibits.



(d)  Exhibits
The exhibits listed below are furnished as part of this Current Report on Form
8-K.
Exhibit No.              Description
99.1                       Biogen's press release dated     October     2    1    , 2020
                         Cover Page Interactive Data File (embedded within the Inline XBRL
104                      document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses